balsalazide has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bettenhausen, D; Jahraus, CD; Rubin, DT; Scherl, EJ | 1 |
| Bettenhausen, D; Jahraus, CD; Malik, U; Sellitti, M; St Clair, WH | 1 |
1 trial(s) available for balsalazide and Cancer of Prostate
| Article | Year |
|---|---|
Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.
Topics: Acute Disease; Aged; Aminosalicylic Acids; Anti-Ulcer Agents; Colon, Sigmoid; Double-Blind Method; Humans; Male; Mesalamine; Phenylhydrazines; Pilot Projects; Proctocolitis; Prostatic Neoplasms; Radiation Injuries; Rectum | 2005 |
1 other study(ies) available for balsalazide and Cancer of Prostate
| Article | Year |
|---|---|
Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.
Topics: Aminosalicylic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Mesalamine; Neoplasms, Radiation-Induced; Phenylhydrazines; Primary Prevention; Prognosis; Prostatic Neoplasms; Radiation Injuries; Rectal Neoplasms; Risk Assessment; Treatment Outcome | 2005 |